Welcome to LookChem.com Sign In|Join Free

CAS

  • or

110351-94-5

Post Buying Request

110351-94-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

110351-94-5 Usage

Chemical Properties

Light yellow solid.

Uses

(4S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione is a key intermediate in the synthesis of Irinotecan (I767500) and Camptothecin (C175150) analogs.

Preparation

Synthesis of (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione: Compound (Formula 4) 4.3 g (100 mmol), 200 ml of dichloromethane, 200 ml of 2M sulfuric acid, stirred at room temperature for 2 h, separated the organic layer, washed with saturated brine, dried, recovered dichloromethane to dryness, and recrystallized from isopropanol to obtain S-tricyclic lactone (Formula 1) 1.5 g, mp 172-174°C, [α]D15+115.6° (C=0.5, chloroform), yield 57%.

Application

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione is the key intermediate for the synthesis of a series of (20S)-camptothecin analogues. Since its isolation from the Chinese plant Camptothecaacuminata by Wall et al. In 1966, (20S)-camptothecin, a pent acyclic natural alkaloid, has re-emerged as one of the most important lead compounds for the discovery of new and selective anticancer drugs because of the disclosure of its unique mechanism of action as a selective inhibitor DNA topoisomerase Ⅰ, a process causing irreversible DNA damage and subsequent cell death. Three camptothecin derivatives with high antitumor activity, topotecan, belotecan, and irinotecan, have been launched as anticancer drugs in clinical practice, and many other analogues are at various stages of clinical development.

Clinical claims and research

Camptothecin is a pentacyclic alkaloid extracted from Camptotheca by Wall et al. in the early 1960s. As an anticancer chemical, the compound has quickly attracted people's attention due to its strong inhibitory activity against leukemia and various other malignant tumors in animal experiments. In the total synthesis of camptothecin, The total synthesis of (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione is research focus.

Check Digit Verification of cas no

The CAS Registry Mumber 110351-94-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,3,5 and 1 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 110351-94:
(8*1)+(7*1)+(6*0)+(5*3)+(4*5)+(3*1)+(2*9)+(1*4)=75
75 % 10 = 5
So 110351-94-5 is a valid CAS Registry Number.

110351-94-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

1.2 Other means of identification

Product number -
Other names (4S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10-trione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110351-94-5 SDS

110351-94-5Synthetic route

(S)-4′-ethyl-4′-hydroxy-7′,8′-dihydrospiro[[1,3]dioxolane-2,6′-pyrano[3,4-f]indolizine]-3′,10′(1′H,4′H)-dione
110351-93-4

(S)-4′-ethyl-4′-hydroxy-7′,8′-dihydrospiro[[1,3]dioxolane-2,6′-pyrano[3,4-f]indolizine]-3′,10′(1′H,4′H)-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water at 60℃; for 3h;100%
With trifluoroacetic acid at 20℃; for 6h;93%
With trifluoroacetic acid for 3h; Ambient temperature;88.9%
C17H21NO7
165674-36-2

C17H21NO7

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water at 60℃; for 3h;100%
(S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione

(S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Stage #1: (S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione With oxygen; ozone In dichloromethane at -40℃; for 0.75h;
Stage #2: With dimethylsulfide In dichloromethane at -40 - 20℃; for 2h;
96%
(S)-4′-ethyl-4′-hydroxy-7′,8′-dihydrospiro[[1,3]dioxolane-2,6′-pyrano[3,4-f]indolizine]-3′,10′(1′H,4′H)-dione
110351-93-4

(S)-4′-ethyl-4′-hydroxy-7′,8′-dihydrospiro[[1,3]dioxolane-2,6′-pyrano[3,4-f]indolizine]-3′,10′(1′H,4′H)-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water at 60℃; for 3h;100%
With trifluoroacetic acid at 20℃; for 6h;93%
With trifluoroacetic acid for 3h; Ambient temperature;88.9%
C17H21NO7
165674-36-2

C17H21NO7

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water at 60℃; for 3h;100%
(S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione

(S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Stage #1: (S,E)-6-benzylidene-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H,6H)-dione With oxygen; ozone In dichloromethane at -40℃; for 0.75h;
Stage #2: With dimethylsulfide In dichloromethane at -40 - 20℃; for 2h;
96%
1,1-dimethylethyl (S)-4-ethyl-3,4,8,10-tetrahydro-4,6-dihydroxy-3,10-dioxo-1H-pyrano[3,4 - f] indolidin-7-carboxylate
183434-04-0

1,1-dimethylethyl (S)-4-ethyl-3,4,8,10-tetrahydro-4,6-dihydroxy-3,10-dioxo-1H-pyrano[3,4 - f] indolidin-7-carboxylate

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
In toluene; trifluoroacetic acid at 110℃; for 2h;93.4%
With trifluoroacetic acid In toluene at 110℃; for 1.66667h;77%
(S)-α-ethyl-α-hydroxy-1,1-(ethylenedioxy)-6-hydroxymethyl-5-oxo-1,2,3,5-tetrahydroindolizine-7-acetamide
110314-10-8

(S)-α-ethyl-α-hydroxy-1,1-(ethylenedioxy)-6-hydroxymethyl-5-oxo-1,2,3,5-tetrahydroindolizine-7-acetamide

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
With trifluoroacetic acid for 3h; Ambient temperature;93%
With sulfuric acid In 1,2-dimethoxyethane
Multi-step reaction with 2 steps
1: acetic acid / 2 h / 70 °C
2: 2N aq. sulfuric acid / 1,2-dimethoxy-ethane / 8 h / 50 °C
View Scheme
4'-ethyl-1',4',7',8'-tetrahydro-4'-hydroxy-3'H,10'H-spiro[1,3-dioxolane-2,6'-pyrano[3,4-f]indolizine]-3',10'-dione
102978-41-6

4'-ethyl-1',4',7',8'-tetrahydro-4'-hydroxy-3'H,10'H-spiro[1,3-dioxolane-2,6'-pyrano[3,4-f]indolizine]-3',10'-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 98.1 percent / DMAP / CH2Cl2 / 4 h / 40 °C
2: aq. K2CO3 / methanol / Ambient temperature
3: 88.9 percent / 80percent aq. CF3COOH / 3 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: 20 h / 75 °C
2: sulfuric acid / 1,2-dimethoxy-ethane
View Scheme
Multi-step reaction with 3 steps
1: 20 h / 75 °C
2: acetic acid / 2 h / 70 °C
3: 2N aq. sulfuric acid / 1,2-dimethoxy-ethane / 8 h / 50 °C
View Scheme
Multi-step reaction with 3 steps
1: 20 h / 70 °C
2: p-toluenesulfonica acid / acetic acid / 7 h / 70 °C
3: 2N aq. sulfuric acid / 1,2-dimethoxy-ethane / 8 h / 50 °C
View Scheme
Multi-step reaction with 3 steps
1.1: copper(l) chloride / dichloromethane / 8 h / 20 °C
2.1: potassium hydroxide / methanol / 5 h / 67 °C
2.2: pH 2-3
3.1: trifluoroacetic acid / 6 h / 20 °C
View Scheme
1,1-ethylenedioxy-5-oxo-(5'-ethyl-2'H,5'H,6'H-6-oxopyran)-[3',4',f]-Δ6(8)-tetrahydroindolizine
127318-97-2

1,1-ethylenedioxy-5-oxo-(5'-ethyl-2'H,5'H,6'H-6-oxopyran)-[3',4',f]-Δ6(8)-tetrahydroindolizine

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: O2, (EtO)3P, tBuONa / dimethylformamide / 2 h / -40 °C
2: 98.1 percent / DMAP / CH2Cl2 / 4 h / 40 °C
3: aq. K2CO3 / methanol / Ambient temperature
4: 88.9 percent / 80percent aq. CF3COOH / 3 h / Ambient temperature
View Scheme
Multi-step reaction with 8 steps
1: 94 percent / DIBAL-H / tetrahydrofuran / 2 h / -78 °C
2: 96 percent / MsCl, TEA / tetrahydrofuran / 24 h / Ambient temperature
3: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
4: pyridine / 3 h / Ambient temperature
5: 93 percent / i-PrNEt / CH2Cl2 / 3 h / Ambient temperature
6: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
7: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
8: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
Multi-step reaction with 5 steps
1: 94 percent / DIBAL-H / tetrahydrofuran / 2 h / -78 °C
2: 96 percent / MsCl, TEA / tetrahydrofuran / 24 h / Ambient temperature
3: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
4: I2, CaCO3 / methanol; H2O / 24 h / Ambient temperature
5: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
4-acetoxy-4-ethyl-6,6-(ethylenedioxy)-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H)-dione
144788-94-3

4-acetoxy-4-ethyl-6,6-(ethylenedioxy)-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,10(4H)-dione

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. K2CO3 / methanol / Ambient temperature
2: 88.9 percent / 80percent aq. CF3COOH / 3 h / Ambient temperature
View Scheme
citrazinic acid
99-11-6

citrazinic acid

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 17 steps
1: 78 percent / POPCl3, Me4NCl / 2 h / 130 - 142 °C
2: 84 percent / tetrahydrofuran / 1 h / 0 °C
3: 100 percent / TMSCl / 12 h / Ambient temperature
4: 89 percent / methanol / 20 h / Heating
5: 1.) n-BuLi / 1.) heptane, hexane, 0 deg C, 30 min, 2.) hexane, heptane, -30 deg C - 0 deg C, 1 h
6: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
7: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
8: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
10: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
11: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
12: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
13: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
14: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
15: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
16: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
17: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
2,6-dichloropyridine-4-carboxylic acid
5398-44-7

2,6-dichloropyridine-4-carboxylic acid

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 16 steps
1: 84 percent / tetrahydrofuran / 1 h / 0 °C
2: 100 percent / TMSCl / 12 h / Ambient temperature
3: 89 percent / methanol / 20 h / Heating
4: 1.) n-BuLi / 1.) heptane, hexane, 0 deg C, 30 min, 2.) hexane, heptane, -30 deg C - 0 deg C, 1 h
5: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
6: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
7: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
9: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
10: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
11: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
12: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
13: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
14: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
15: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
16: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
1-(2,6-dichloropyridin-4-yl)propan-1-one
183433-62-7

1-(2,6-dichloropyridin-4-yl)propan-1-one

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 15 steps
1: 100 percent / TMSCl / 12 h / Ambient temperature
2: 89 percent / methanol / 20 h / Heating
3: 1.) n-BuLi / 1.) heptane, hexane, 0 deg C, 30 min, 2.) hexane, heptane, -30 deg C - 0 deg C, 1 h
4: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
5: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
6: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
8: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
9: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
10: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
11: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
12: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
13: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
14: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
15: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
5-Benzyloxymethyl-4-(1-hydroxy-1-hydroxymethyl-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester
183433-74-1

5-Benzyloxymethyl-4-(1-hydroxy-1-hydroxymethyl-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
2: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
3: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
4: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
5: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
6: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
7: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
5-Benzyloxymethyl-4-((S)-1-hydroxy-1-hydroxymethyl-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester
183433-75-2

5-Benzyloxymethyl-4-((S)-1-hydroxy-1-hydroxymethyl-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
2: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
3: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
4: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
5: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
6: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine
183433-63-8

2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 14 steps
1: 89 percent / methanol / 20 h / Heating
2: 1.) n-BuLi / 1.) heptane, hexane, 0 deg C, 30 min, 2.) hexane, heptane, -30 deg C - 0 deg C, 1 h
3: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
4: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
5: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
7: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
8: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
9: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
10: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
11: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
12: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
13: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
14: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
6-chloro-4-(2-ethyl-1,3-dioxolan-2-yl)-2-methoxypyridine
183433-64-9

6-chloro-4-(2-ethyl-1,3-dioxolan-2-yl)-2-methoxypyridine

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1: 1.) n-BuLi / 1.) heptane, hexane, 0 deg C, 30 min, 2.) hexane, heptane, -30 deg C - 0 deg C, 1 h
2: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
3: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
4: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
6: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
7: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
8: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
9: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
10: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
11: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
12: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
13: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
6-Chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridine-3-carbaldehyde
183433-65-0

6-Chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridine-3-carbaldehyde

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1: 71 percent / NaBH4, n-Bu4NCl / H2O / 18 h
2: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
3: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
5: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
6: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
7: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
8: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
9: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
10: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
11: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
12: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
[6-Chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridin-3-yl]-methanol
183433-66-1

[6-Chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridin-3-yl]-methanol

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1: 99.3 percent / t-BuOK / tetrahydrofuran / 1 h / 20 - 30 °C
2: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
4: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
5: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
6: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
7: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
8: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
9: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
10: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
11: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
(S)-4-Ethyl-3,4-dihydroxy-8-methoxy-3,4-dihydro-1H-pyrano[3,4-c]pyridine-6-carboxylic acid propyl ester
194999-55-8

(S)-4-Ethyl-3,4-dihydroxy-8-methoxy-3,4-dihydro-1H-pyrano[3,4-c]pyridine-6-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
2: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
3: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
4: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
propyl (S)-4-ethyl-3,4,7,8-tetrahydro-4-hydroxy-3,8-dioxo-1H-pyrano[3,4-c] pyridine-6-carboxylate
183434-02-8

propyl (S)-4-ethyl-3,4,7,8-tetrahydro-4-hydroxy-3,8-dioxo-1H-pyrano[3,4-c] pyridine-6-carboxylate

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
2: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
propyl (S)-4-ethyl-3,4-dihydro-4-hydroxy-8-methoxy-3-oxo-1H-pyrano[3,4-c]pyridine-6-carboxylate
183434-00-6

propyl (S)-4-ethyl-3,4-dihydro-4-hydroxy-8-methoxy-3-oxo-1H-pyrano[3,4-c]pyridine-6-carboxylate

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
2: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
3: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
3-Benzyloxymethyl-6-chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridine
183433-67-2

3-Benzyloxymethyl-6-chloro-4-(2-ethyl-[1,3]dioxolan-2-yl)-2-methoxy-pyridine

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 89 percent / Pd(OAc)2, K2CO3, DPP / dimethylformamide / 16 h / 90 °C / 775.7 Torr
3: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
4: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
5: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
6: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
7: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
8: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
9: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
10: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
5-Benzyloxymethyl-6-methoxy-4-(1-methylene-propyl)-pyridine-2-carboxylic acid propyl ester
183433-72-9

5-Benzyloxymethyl-6-methoxy-4-(1-methylene-propyl)-pyridine-2-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
2: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
3: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
4: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
5: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
6: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
7: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
8: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
5-Benzyloxymethyl-4-((S)-1-formyl-1-hydroxy-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester
183433-96-7

5-Benzyloxymethyl-4-((S)-1-formyl-1-hydroxy-propyl)-6-methoxy-pyridine-2-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
2: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
3: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
4: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
5: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
5-Benzyloxymethyl-4-(2-ethyl-[1,3]dioxolan-2-yl)-6-methoxy-pyridine-2-carboxylic acid propyl ester
183433-68-3

5-Benzyloxymethyl-4-(2-ethyl-[1,3]dioxolan-2-yl)-6-methoxy-pyridine-2-carboxylic acid propyl ester

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 9 steps
2: 92 percent / OsO4, Me3NO*2H2O / 2-methyl-propan-2-ol / 24 h / 40 °C
3: 76 percent / PS-30 catalyst / various solvent(s) / 48 h
4: 100 percent / NaOCl, 4-acetoxy-TEMPO, KBr, NaHCO3 / CH2Cl2; H2O / 0.67 h
5: 96 percent / H2 / Pd/C / methanol / 96 h / 775.7 Torr / Ambient temperature; other catalyst, reaction time, temperature
6: 99 percent / TEMPO, KBr, NaHCO3, NaOCl / CH2Cl2; H2O / 0.5 h
7: 89 percent / TMSCl, NaI / acetonitrile / 6 h / 0 - 20 °C
8: 74 percent / Cs2CO3 / dimethylsulfoxide / 21 h / 47 - 50 °C
9: 93.4 percent / trifluoroacetic acid; toluene / 2 h / 110 °C
View Scheme
C15H17NO4
165674-31-7

C15H17NO4

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
2: pyridine / 3 h / Ambient temperature
3: 93 percent / i-PrNEt / CH2Cl2 / 3 h / Ambient temperature
4: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
5: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
6: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
Multi-step reaction with 3 steps
1: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
2: I2, CaCO3 / methanol; H2O / 24 h / Ambient temperature
3: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
C15H19NO5
165674-30-6

C15H19NO5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 96 percent / MsCl, TEA / tetrahydrofuran / 24 h / Ambient temperature
2: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
3: pyridine / 3 h / Ambient temperature
4: 93 percent / i-PrNEt / CH2Cl2 / 3 h / Ambient temperature
5: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
6: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
7: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
Multi-step reaction with 4 steps
1: 96 percent / MsCl, TEA / tetrahydrofuran / 24 h / Ambient temperature
2: (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, K2OsO2, CH3SO2NH2 / 2-methyl-propan-2-ol; H2O / 96 h / Ambient temperature
3: I2, CaCO3 / methanol; H2O / 24 h / Ambient temperature
4: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
C17H23NO7

C17H23NO7

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
2: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
C17H21NO7

C17H21NO7

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 93 percent / i-PrNEt / CH2Cl2 / 3 h / Ambient temperature
2: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
3: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
4: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
C19H25NO8

C19H25NO8

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
2: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
3: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
C15H19NO6

C15H19NO6

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: pyridine / 3 h / Ambient temperature
2: 93 percent / i-PrNEt / CH2Cl2 / 3 h / Ambient temperature
3: 92 percent / aq. K2CO3 / methanol / 2 h / Ambient temperature
4: 84 percent / pyridinium chlorochromate, AcONa, molecular sieves 4 Angstroem / 24 h / Ambient temperature
5: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
Multi-step reaction with 2 steps
1: I2, CaCO3 / methanol; H2O / 24 h / Ambient temperature
2: 100 percent / aq. HCl / tetrahydrofuran; H2O / 3 h / 60 °C
View Scheme
(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

2-amino-5-methylthiopropiophenone
124623-17-2

2-amino-5-methylthiopropiophenone

(S)-4,11-Diethyl-4-hydroxy-9-methylsulfanyl-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

(S)-4,11-Diethyl-4-hydroxy-9-methylsulfanyl-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 24h; Heating;99%
1-(2-amino-phenyl)-3-trimethylsilanyl-propan-1-one
1609324-12-0

1-(2-amino-phenyl)-3-trimethylsilanyl-propan-1-one

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

(4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3':4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

(4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3':4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid; acetic acid In toluene at 100℃; for 20h;98%
2-(3'-trimethylsilylpropionyl)-N-Boc-aniline
1609257-42-2

2-(3'-trimethylsilylpropionyl)-N-Boc-aniline

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
110351-94-5

(4S)-4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione

(4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3':4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

(4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3':4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid; acetic acid In toluene at 100℃; for 24h;96%

110351-94-5Relevant articles and documents

Synthetic studies on camptothecins. Part 3

Kuang, Yun-Yan,Niu, Jing-Ze,Chen, Fen-Er

, p. 2094 - 2099 (2010)

A concise and efficient asymmetric process for the total synthesis of (20S)-7-ethyl-10-hydroxycamptothecin (=SN-38; 1f), an active metabolic form of the prodrug irinotecan, is described. This approach features the enantioselective cyanosilylation of indolizinone 4 into the corresponding cyanohydrin 5, mediated by a bifunctional thiourea-based cinchona alkaloid under mild conditions, and I2-catalyzed Friedlnder condensation of the tricyclic lactone 6 and 2-amino-5-hydroxy propiophenone (=1-(2-amino-5- hydroxyphenyl)propan-1-one). Copyright

Enantioselective synthesis of 20(S)-camptothecin using an enzyme- catalyzed resolution

Imura, Akihiro,Itoh, Motohiro,Miyadera, Akihiko

, p. 2285 - 2291 (1998)

The important key intermediate of a 20(S)-camptothecin synthesis was prepared enantioselectively using an enzyme-catalyzed resolution. A commercially available papain was found to exhibit the highest enantioselectivity with moderate activity, and the (S)-enantiomer of 99% ee was obtained as the remaining substrate.

Camptothecin derivative and preparation method and application thereof

-

, (2020/01/03)

The invention relates to a compound with a structure shown in a formula (I), a stereoisomer of the compound and a pharmaceutically acceptable salt form of the compound, and further relates to a preparation method of the compound, a pharmaceutical composition containing therapeutically effective dose of the compound, and application of the pharmaceutical composition in the preparation for the prevention and/or treatment of cancer. The compound is a camptothecin derivative with a novel structure with 10 site and 11 site of a stem nucleus introduced with methylene dioxy groups and 7-site introduced with different substituted groups. The raw materials of the preparation method can be obtained easily, a synthetic method is simple, a purification method is simple and fast, the compound has excellent cytotoxic activity in vitro and excellent antitumor effect in vivo, and the compound has broad medicinal prospects.(Please see the specification for the formula).

COMPOUND OF CAMPTOTHECIN AND PREPARATION AND USE THEREOF

-

Paragraph 0097, (2015/05/05)

The present disclosure relates to a compound of formula I, a pharmaceutical composition thereof and the use thereof as an anti-tumor drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110351-94-5